Kim Dueholm Partner, Novo Ventures

Kim Dueholm is a Partner in Novo Ventures, Novo A/S. Kim obtained his MSc in chemistry/business administration from Odense University in 1991 and his PhD in organic chemistry from the University of Copenhagen in 1995. In 1995 he joined Novo Nordisk A/S and has held various positions ranging from Information Specialist and Patent Portfolio Analyst to Principal Scientific Analyst. Kim's international experience includes research and venture fund experience from California, USA, and research experience from Osaka, Japan. Kim joined Novo A/S in November 2000. Kim is a director of Orphazyme and a former director of Novexel, Neurokey, Symphogen, Nuevolution and Core.